ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $54,000 | -3.6% | 10,045 | +0.4% | 0.03% | -46.4% |
| Q3 2016 | $56,000 | -62.4% | 10,000 | -50.1% | 0.06% | -72.5% |
| Q1 2016 | $149,000 | +79.5% | 20,045 | +99.6% | 0.20% | +300.0% |
| Q4 2015 | $83,000 | -75.7% | 10,045 | -64.6% | 0.05% | -75.9% |
| Q2 2015 | $341,000 | -62.8% | 28,408 | -66.6% | 0.21% | -65.4% |
| Q1 2015 | $917,000 | +201.6% | 85,090 | +41.8% | 0.61% | +273.2% |
| Q4 2014 | $304,000 | +1069.2% | 60,000 | +500.0% | 0.16% | +811.1% |
| Q3 2014 | $26,000 | -35.0% | 10,000 | 0.0% | 0.02% | -28.0% |
| Q2 2014 | $40,000 | -65.2% | 10,000 | -60.0% | 0.02% | -59.7% |
| Q1 2014 | $115,000 | +5.5% | 25,000 | 0.0% | 0.06% | +17.0% |
| Q4 2013 | $109,000 | -44.9% | 25,000 | -50.0% | 0.05% | -55.8% |
| Q3 2013 | $198,000 | +465.7% | 50,000 | +199.4% | 0.12% | +380.0% |
| Q2 2013 | $35,000 | – | 16,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |